EUVIMEDEUVIMED entdecken
Crossref

CTLA4-Ig sustains osteogenic potential and inhibits osteoclastogenesis in Staphylococcus aureus osteomyelitis

Rongjie Lin, Yiqing Huang, Zhenbin Chen, Xi Zeng, Yao Wang, Shaohuang Weng, Yu Cheng, Min Chen

Bone · 2026

DOI: 10.1016/j.bone.2025.117731 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bone, 2026. Verfasst von Rongjie Lin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Fujian Medical University Union Hospital, Fuzhou, 350001, China. Hauptthemen laut MEDLINE: Osteogenesis, Osteomyelitis, Staphylococcus aureus, Osteoclasts. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Fujian Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteomyelitis (OM) is a severe bone-destructive disease characterized by infection and inflammation. Transcriptomic analysis of datasets GSE18043 and GSE30119 identified CTLA4 as a key regulator associated with immune modulation and osteogenic differentiation. Subsequent bioinformatic and immune infiltration analyses revealed that CTLA4 expression correlated with increased anti-inflammatory macrophage infiltration and activation of the Wnt/β-catenin signaling pathway of osteoblasts. Functionally, CTLA4-Ig promoted osteogenic differentiation, enhanced matrix mineralization, and upregulated osteogenic markers in MC3T3-E1 cells, while concurrently inhibiting osteoclast formation and bone resorption activity. In a Staphylococcus aureus-induced rat OM model, histological and immunohistochemical analyses further confirmed enhanced osteoblast activity and reduced osteoclast presence in the CTLA4-Ig treated group. CTLA4-Ig administration preserved bone structural integrity by modulating the inflammatory microenvironment, characterized by reduced expression of pro-inflammatory cytokines, increased levels of anti-inflammatory cytokines, enhanced osteogenic regeneration, and a reduction in bacterial burden. Collectively, these findings established CTLA4-Ig as a dual-action modulator that promoted bone regeneration while inhibiting bone destruction, offering a promising therapeutic strategy for OM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteogenesisOsteomyelitisStaphylococcus aureusOsteoclastsAbataceptStaphylococcal InfectionsAnimalsMiceRatsCell DifferentiationMaleRats, Sprague-DawleyOsteoblastsCell LineCytokines

Stichwörter der Autor:innen

CTLA4Osteogenic differentiationOsteomyelitisStaphylococcus aureusWnt/β-catenin

Substanzen

AbataceptCytokines

Autor:innen und Institutionen

  • Department of Orthopedic Surgery, Fujian Medical University Union Hospital, Fuzhou, 350001, China.
  • Department of Pharmaceutical Analysis, School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China.
  • Department of Pharmacy, Fujian Medical University Union Hospital, Fuzhou, 350001, China. Electronic address: 86cy@163.com.
  • Department of Orthopedic Surgery, Fujian Medical University Union Hospital, Fuzhou, 350001, China. Electronic address: chenminfz006@163.com.

Förderung

  • Fujian Provincial Natural Science Foundation

Zitieren

APA

Lin, R., Huang, Y., Chen, Z., Zeng, X., Wang, Y., Weng, S., Cheng, Y., & Chen, M. (2026). CTLA4-Ig sustains osteogenic potential and inhibits osteoclastogenesis in Staphylococcus aureus osteomyelitis. Bone. https://doi.org/10.1016/j.bone.2025.117731

Vancouver

Lin R, Huang Y, Chen Z, Zeng X, Wang Y, Weng S, et al. CTLA4-Ig sustains osteogenic potential and inhibits osteoclastogenesis in Staphylococcus aureus osteomyelitis. Bone. 2026. doi:10.1016/j.bone.2025.117731

BibTeX
@article{Lin2026,
  author = {Lin, Rongjie and Huang, Yiqing and Chen, Zhenbin and Zeng, Xi and Wang, Yao and Weng, Shaohuang and Cheng, Yu and Chen, Min},
  title = {CTLA4-Ig sustains osteogenic potential and inhibits osteoclastogenesis in Staphylococcus aureus osteomyelitis},
  journal = {Bone},
  year = {2026},
  doi = {10.1016/j.bone.2025.117731}
}
Kostenlos starten →